In RA Treatment, Don't Overlook Underlying CV Risks

Disease-modifying antirheumatic drugs can reduce some cardiovascular risk in patients with rheumatoid arthritis, but questions remain if that's enough when statin use lags.

Related Keywords

Michaels Garshick ,Los Angeles ,Jont Giles ,Langone Health ,Sinai Inflammatory Arthritis Clinical Center At Cedars ,Annual Cardiometabolic Risk ,Inflammatory Conditions ,Modifying Antirheumatic Drugs ,